Protara Therapeutics, Inc. Interest Income, Other
Protara Therapeutics, Inc. (TARA) reported Interest Income, Other of $659.00 thousand for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeOther · last filed 2024-11-12
- Protara Therapeutics, Inc. interest income, other for the quarter ending 2024-09-30 was $659.00K, a 7.18% decline year-over-year.
- Protara Therapeutics, Inc. interest income, other for the quarter ending 2024-06-30 was $1.13M, a 59.15% increase year-over-year.
- Protara Therapeutics, Inc. interest income, other for the quarter ending 2024-03-31 was $679.00K, a 12.23% increase year-over-year.
- Protara Therapeutics, Inc. interest income, other for the quarter ending 2023-12-31 was $702.00K, a 11.08% increase year-over-year.
- Protara Therapeutics, Inc. interest income, other for fiscal 2023 was $2.73M, a 22.29% increase from fiscal 2022.
- Protara Therapeutics, Inc. interest income, other for fiscal 2022 was $2.23M, a 12.97% increase from fiscal 2021.
- Protara Therapeutics, Inc. interest income, other for fiscal 2021 was $1.97M, a 294.80% increase from fiscal 2020.
- Protara Therapeutics, Inc. interest income, other for fiscal 2020 was $500.00K.
| Period end | Interest Income, Other 3 month | Interest Income, Other 6 month | Interest Income, Other 9 month | Interest Income, Other 12 month |
|---|---|---|---|---|
| 2024-09-30 | $659.00K 10-Q · filed 2024-11-12 | $1.79M derived: sum of 2 quarters · filed 2024-11-12 | $2.47M 10-Q · filed 2024-11-12 | $3.17M derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | $1.13M 10-Q · filed 2024-08-06 | $1.81M 10-Q · filed 2024-08-06 | $2.51M derived: sum of 3 quarters · filed 2024-08-06 | $3.22M derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-03-31 | $679.00K 10-Q · filed 2024-05-02 | $1.38M derived: sum of 2 quarters · filed 2024-05-02 | $2.09M derived: sum of 3 quarters · filed 2024-11-12 | $2.80M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-12-31 | $702.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $1.41M derived: sum of 2 quarters · filed 2024-11-12 | $2.12M derived: sum of 3 quarters · filed 2024-11-12 | $2.73M 10-K · filed 2024-03-13 |
| 2023-09-30 | $710.00K 10-Q · filed 2024-11-12 | $1.42M derived: sum of 2 quarters · filed 2024-11-12 | $2.02M 10-Q · filed 2024-11-12 | $2.66M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $710.00K 10-Q · filed 2024-08-06 | $1.31M 10-Q · filed 2024-08-06 | $1.95M derived: sum of 3 quarters · filed 2024-08-06 | $2.50M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $605.00K 10-Q · filed 2024-05-02 | $1.24M derived: sum of 2 quarters · filed 2024-05-02 | $1.79M derived: sum of 3 quarters · filed 2024-05-02 | $2.31M derived: sum of 4 quarters · filed 2024-05-02 |
| 2022-12-31 | $632.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $1.19M derived: sum of 2 quarters · filed 2024-03-13 | $1.70M derived: sum of 3 quarters · filed 2024-03-13 | $2.23M 10-K · filed 2024-03-13 |
| 2022-09-30 | $557.00K 10-Q · filed 2023-11-03 | $1.07M derived: sum of 2 quarters · filed 2023-11-03 | $1.60M 10-Q · filed 2023-11-03 | $2.11M derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | $512.00K 10-Q · filed 2023-08-03 | $1.04M 10-Q · filed 2023-08-03 | $1.56M derived: sum of 3 quarters · filed 2023-08-03 | $2.10M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $529.00K 10-Q · filed 2023-05-04 | $1.04M derived: sum of 2 quarters · filed 2023-05-04 | $1.59M derived: sum of 3 quarters · filed 2023-05-04 | $2.10M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $516.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $1.06M derived: sum of 2 quarters · filed 2023-03-08 | $1.58M derived: sum of 3 quarters · filed 2023-03-08 | $1.97M 10-K · filed 2023-03-08 |
| 2021-09-30 | $547.00K 10-Q · filed 2022-11-03 | $1.06M derived: sum of 2 quarters · filed 2022-11-03 | $1.46M 10-Q · filed 2022-11-03 | |
| 2021-06-30 | $513.00K 10-Q · filed 2022-08-09 | $911.00K 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $397.00K 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | $500.00K 10-K · filed 2022-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |